Home / Oxaliplatin / Czechia
CZ ATC L01XA03 · updated 2 Nov 2026
Oxaliplatin shortage in Czechia
Is there an Oxaliplatin shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Oxaliplatin products are reported short in Czechia, the first since 2 Mar 2026. The company estimate for the return is 4 Jan 2027. Main reason: manufacturing problem.
Also short in United States, Canada, Germany, Italy, Spain, Ireland, Austria, Belgium, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | OXALIPLATIN ACCORD 5MG/ML 5MG/ML INF CNC SOL 1X10ML | Accord (Intas) | 2 Mar 2026 | 4 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | OXALIPLATIN TEVA 5MG/ML 5MG/ML INF CNC SOL 1X20ML | Teva Pharmaceuticals CR, s.r.o., Praha | 15 Jul 2026 | not given | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.